📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
BULLISH
TOTAL VIEWS
19
ETON Latest News & AI Sentiment Analysis
2 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 5 ARTICLES
Eton Pharmaceuticals forecasts 2026 revenue to exceed $145M while targeting adjusted EBITDA margin above 35% (NASDAQ:ETON)
Eton Pharmaceuticals reported record Q2 revenue and raised full-year 2026 guidance to exceed $145M, signaling continued commercial...
Eton Pharmaceuticals, Inc. (ETON) Q2 2026 Earnings Call Transcript
This article is a transcript publication of Eton Pharmaceuticals' (ETON) Q2 2026 earnings call, a scheduled procedural disclosure rather...
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
Eton Pharmaceuticals (ETON) has acquired U.S. rights to ASN-001, a late-stage topical gel candidate targeting proliferating superficial...
Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
Eton Pharmaceuticals (ETON) has scheduled release of its Q2 2026 financial results for August 13, 2026, with a management conference...
Eton Stock: Here Is How I Handle My Position With The Stock Skyrocketing (NASDAQ:ETON)
Eton Pharmaceuticals (ETON) continues to execute its focused strategy of acquiring ultra-rare disease therapies, now managing a...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice